Ultrasound-guided foam sclerotherapy as a therapeutic modality in venous ulceration

The Surgeon ◽  
2021 ◽  
Author(s):  
D.P. Joyce ◽  
S. De Freitas ◽  
E.Y. Woo ◽  
T.Y. Tang ◽  
M. Tubassam ◽  
...  
2014 ◽  
Vol 31 (1) ◽  
pp. 34-41 ◽  
Author(s):  
G Grover ◽  
A Tanase ◽  
A Elstone ◽  
S Ashley

Introduction Ultrasound-guided foam sclerotherapy is a minimally invasive treatment option used for ablation of axial and perforator reflux for chronic venous ulceration. Active ulceration presents a significant health burden in both the primary and secondary care setting. The objective of this study is to determine ulcer healing rates at 24 weeks and 12 months, and ulcer recurrence rates at one year for chronic venous ulcers after ultrasound-guided foam sclerotherapy. Methods Between 2007 and 2012, 54 patients underwent ultrasound-guided foam sclerotherapy for clinical, aetiological, anatomical and pathological C6 ulcers. All patients were followed up clinically, and venous duplex was performed on all legs before and after treatment. A prospectively maintained database was analysed to determine venous truncal occlusion rates, 24-week and 12-month healing and recurrence rates (using Kaplan–Meier survival analysis). Results Fifty-seven ulcerated legs, 39 primary and 18 with recurrent superficial venous reflux were analysed. Median time of active ulceration at presentation was 15.2 months (range 5 months to 17 years). At a median follow-up of 2.7 months, 90% (51 legs) achieved full truncal occlusion after one session, 4% (2) short segment occlusion and 5% (3) failed to occlude and one patient died and was lost to follow-up; 13/57 (23%) required a second session of treatment for completion of treatment, recanalisations and to treat perforator disease, 88% (50/57) ulcers healed at a median of 5.3 months (interquartile range 2.9–8.4 months) following their first ultrasound-guided foam sclerotherapy treatment. The 24-week and 12-month estimated healing rates were 53% and 72%, respectively. The estimated 12-month recurrence rate was 9.2%. There were no reported incidences of deep venous thrombosis or neurological symptoms. Conclusion This study affirms the role of ultrasound-guided foam sclerotherapy as a safe and effective option for abolition of superficial reflux.


2009 ◽  
Vol 38 (6) ◽  
pp. 764-769 ◽  
Author(s):  
K.A.L. Darvall ◽  
G.R. Bate ◽  
D.J. Adam ◽  
S.H. Silverman ◽  
A.W. Bradbury

2013 ◽  
Vol 11 (8) ◽  
pp. 740
Author(s):  
Andrei Tanase ◽  
Gagandeep Grover ◽  
Alan Elstone ◽  
Simon Ashley

2016 ◽  
Vol 31 (7) ◽  
pp. 506-513 ◽  
Author(s):  
Julia K Howard ◽  
Fiona JA Slim ◽  
Margaret C Wakely ◽  
Lorraine G Emerson ◽  
Colin E Davies ◽  
...  

Objectives The aim was to assess vein recanalisation and ulcer recurrence in patients with chronic venous ulceration following ultrasound-guided foam sclerotherapy. Method Open (CEAP 6) or recently healed (CEAP 5) chronic venous leg ulcers were treated with foam sclerotherapy between July 2010 and August 2012. Venous duplex scans were performed two weeks and one and two years post treatment, recording recanalisation and reflux. One- and two-year ulcer recurrence rates were calculated using Kaplan–Meier survival analysis. Results A total of 100 legs were treated in 92 patients; 86 were CEAP 5 and 14 were CEAP 6. At two weeks complete or short segment occlusion was demonstrated in 99/100 legs. Complete follow-up was 93% at one year and 88% at two years. Complete and segmental recanalisation with new reflux was recorded in 11/93 (12%) legs and 25/93 (27%) legs, respectively (overall 36/93; 39%) at one year; and 6/88 (7%) legs and 15/88 (17%) legs, respectively (overall 21/88; 24%) at two years. Kaplan–Meier survival analysis shows 64% ulcers healed at 24 weeks and 86% at one year. Ulcer recurrence rate at one and two years was 2.3% and 5.1%. Conclusions Over one-third of superficial veins treated with foam sclerotherapy recanalised at one year and just under a quarter of superficial veins recanalised at two years. Despite this, ulcer recurrence rates were low, and recanalisation failed to predict recurrence.


2016 ◽  
Vol 32 (7) ◽  
pp. 448-452 ◽  
Author(s):  
Kathleen Gibson ◽  
Neil Khilnani ◽  
Marlin Schul ◽  
Mark Meissner

The American College of Phlebology Guidelines Committee performed a systematic review of the literature regarding the clinical impact and treatment of incompetent accessory saphenous veins. Using an accepted process for guideline developments, we developed a consensus opinion that patients with symptomatic incompetence of the accessory great saphenous veins (anterior and posterior accessory saphenous veins) be treated with endovenous thermal ablation (laser or radiofrequency) or ultrasound-guided foam sclerotherapy to eliminate symptomatology (Recommendation Grade 1C).


Author(s):  
Fanny Rodriguez Santos ◽  
Victoria Loson ◽  
Agustin Coria ◽  
Mariana Dotta ◽  
Carolina Marque Fosser ◽  
...  

2021 ◽  
Vol 21 (3) ◽  
Author(s):  
Satyendra K. TIWARY ◽  
Sartaz ALAM ◽  
Pankaj SUREKA ◽  
Puneet KUMAR ◽  
Ajay K. KHANNA

Sign in / Sign up

Export Citation Format

Share Document